Bibliography
- O'Donnell AE. Bronchiectasis. Chest 2008;134(4):815-23
- Shoemark A, Ozerovitch L, Wilson R. Aetiology in adult patients with bronchiectasis. Respir Med 2007;101(6):1163-70
- Drobnic ME, Sune P, Montoro JB, Inhaled tobramycin in non-cystic fibrosis patients with bronchiectasis and chronic bronchial infection with Pseudomonas aeruginosa. Ann Pharmacother 2005;39(1):39-44
- Michalopoulos A, Papadakis E. Inhaled anti-infective agents: emphasis on colistin. Infection 2010;38(2):81-8
- Available from: http://www.clinicaltrials.gov/ct2/show/NCT00749866?term=nebulized+gentamicin&rank=1Long Term Nebulised Gentamicin in Patients With Bronchiectasis
- Murray M, Govan JRW, Doherty CJ, A randomised controlled trial of nebulised gentamicin in non-cystic fibrosis bronchiectasis. Am J Respir Crit Care Med 2011;183(4):491-9
- Crowther Labiris NR, Holbrook AM, Chrystyn H, Dry powder versus intravenous and nebulized gentamicin in cystic fibrosis and bronchiectasis. A pilot study. Am J Respir Crit Care Med 1999;160(5 Pt 1):1711-16
- Lin HC, Cheng HF, Wang CH, Inhaled gentamicin reduces airway neutrophil activity and mucus secretion in bronchiectasis. Am J Respir Crit Care Med 1997;155(6):2024-9